Greg Renza

Stock Analyst at Truist Financial

Total Price Targets

3

Stocks Covered

3

Sectors

Healthcare

Most Recent

Mar 17, 2026

Notable Calls (Last 12 Months)

Most Bullish

CATX+135.8%
Perspective Therapeutics, Inc.
$12.00 targetMar 17, 2026
AGIO+37.3%
Agios Pharmaceuticals, Inc.
$39.00 targetFeb 12, 2026
REGN+6.2%
Regeneron Pharmaceuticals, Inc.
$818.00 targetMar 9, 2026

Most Bearish

Stocks Covered by Greg Renza

Symbol	Company	Latest Target	Current Price	Upside	# Targets	Last Updated
CATX	Perspective Therapeutics, Inc.	$12.00	$3.90	+208.1%	1	Mar 17, 2026
REGN	Regeneron Pharmaceuticals, Inc.	$818.00	$703.72	+16.2%	1	Mar 9, 2026
AGIO	Agios Pharmaceuticals, Inc.	$39.00	$28.15	+38.5%	1	Feb 12, 2026

Recent Activity

Mar 17, 2026— Set$12.00price target onCATX(Perspective Therapeutics, Inc.)
Mar 9, 2026— Set$818.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
Feb 12, 2026— Set$39.00price target onAGIO(Agios Pharmaceuticals, Inc.)

Frequently Asked Questions

Who is Greg Renza?

Greg Renza is a stock analyst at Truist Financial covering 3 stocks primarily in Healthcare. They have issued 3 price targets since Feb 12, 2026.

What stocks does Greg Renza cover?

Greg Renza currently covers 3 stocks, including CATX, REGN, AGIO.

What is Greg Renza's latest price target?

Greg Renza's most recent price target was $12.00 on CATX (Perspective Therapeutics, Inc.), set on Mar 17, 2026.

What is Greg Renza's highest price target?

Greg Renza's highest issued price target is $818.00 on REGN, set on Mar 9, 2026.

More Analysts at Truist Financial

Scot Ciccarelli

Truist Financial

Truist Financial

Truist Financial

Truist Financial

Coverage based on publicly published price targets. Not investment advice.